Enovis Corporation

ENOVNYSE • USD
17.77 USD
↘ 0.28 (1.55%)AT CLOSE (03:59 PM EDT)
17.75
↘ 0.02 (0.11%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
17.75
↘ 0.02 (0.11%)
🔴Market: CLOSED

Enovis Corporation (ENOV) is currently trading at $17.77. Our models show a "Strong Sell" technical signal alongside a "Neutral" fundamental rating. This is driven by a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest ENOV is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Oct 2, 2026.

Open?$18.27
High?$18.27
Low?$17.68
Prev. Close?$18.05
Volume?1.4M
Avg. Volume?1.8M
VWAP?$17.93
Rel. Volume?0.76x
Bid / Ask
Bid?$17.35 × 100
Ask?$18.00 × 200
Spread?$0.65
Midpoint?$17.68
Valuation & Ratios
Market Cap?1.0B
Shares Out?57.7M
Float?56.0M
Float %?97.1%
P/E Ratio?N/A
P/B Ratio?0.69
EPS?-$19.10
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
Employees
7.8K
Market Cap
1.0B
Industry
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Listed
2008-05-08
Address
2900 LAKE VISTA DRIVE
LEWISVILLE, TX 75067
Phone: (302) 252-9160
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
2
Momentum?
95
Short Sent.?
51
Piotroski F-Score?4/9Mixed
Altman Z-Score?-0.39Distress
Confidence?51%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?16.94%High
Short Interest?9.5M
Days to Cover?3.5
Free Float56.0M
Avg Daily Volume2.7M
Settlement Date2026-09-15
Financial Health
Current Ratio?1.98Adequate
Quick Ratio?1.00Adequate
Cash Ratio?0.02Low
Debt/Equity?0.87Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.69CHEAP▾
P/S?
Peers
100
S&P
97
0.45CHEAP▾
P/FCF?
Peers
100
S&P
70
16.1CHEAP▾
EV/EBITDA?
Peers
100
S&P
93
7.1CHEAP▾
EV/Sales?
Peers
100
S&P
91
1.00CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-74.6%WEAK▾
ROA?
S&P
3
-29.3%WEAK▾
Cash Flow & Enterprise
FCF?$63.7M
Enterprise Value?$2.3B
Fundamentals ratios updated end of day